Literature DB >> 19113927

Positive regulation of adult bone formation by osteoblast-specific transcription factor osterix.

Wook-Young Baek1, Min-A Lee, Ji Won Jung, Shin-Yoon Kim, Haruhiko Akiyama, Benoit de Crombrugghe, Jung-Eun Kim.   

Abstract

Osterix (Osx) is essential for osteoblast differentiation and bone formation, because mice lacking Osx die within 1 h of birth with a complete absence of intramembranous and endochondral bone formation. Perinatal lethality caused by the disruption of the Osx gene prevents studies of the role of Osx in bones that are growing or already formed. Here, the function of Osx was examined in adult bones using the time- and site-specific Cre/loxP system. Osx was inactivated in all osteoblasts by Col1a1-Cre with the activity of Cre recombinase under the control of the 2.3-kb collagen promoter. Even though no bone defects were observed in newborn mice, Osx inactivation with 2.3-kb Col1a1-Cre exhibited osteopenia phenotypes in growing mice. BMD and bone-forming rate were decreased in lumbar vertebra, and the cortical bone of the long bones was thinner and more porous with reduced bone length. The trabecular bones were increased, but they were immature or premature. The expression of early marker genes for osteoblast differentiation such as Runx2, osteopontin, and alkaline phosphatase was markedly increased, but the late marker gene, osteocalcin, was decreased. However, no functional defects were found in osteoclasts. In summary, Osx inactivation in growing bones delayed osteoblast maturation, causing an accumulation of immature osteoblasts and reducing osteoblast function for bone formation, without apparent defects in bone resorption. These findings suggest a significant role of Osx in positively regulating osteoblast differentiation and bone formation in adult bone.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19113927      PMCID: PMC4020416          DOI: 10.1359/jbmr.081248

Source DB:  PubMed          Journal:  J Bone Miner Res        ISSN: 0884-0431            Impact factor:   6.741


  32 in total

Review 1.  Bone development: interaction of molecular components and biophysical forces.

Authors:  Francisco Forriol; Frederic Shapiro
Journal:  Clin Orthop Relat Res       Date:  2005-03       Impact factor: 4.176

2.  Regulation of skeletal development by the Runx family of transcription factors.

Authors:  Toshihisa Komori
Journal:  J Cell Biochem       Date:  2005-06-01       Impact factor: 4.429

3.  Cortical bone development under the growth plate is regulated by mechanical load transfer.

Authors:  E Tanck; G Hannink; R Ruimerman; P Buma; E H Burger; R Huiskes
Journal:  J Anat       Date:  2006-01       Impact factor: 2.610

4.  Inhibition of Wnt signaling by the osteoblast-specific transcription factor Osterix.

Authors:  Chi Zhang; Kyucheol Cho; Yehong Huang; Jon P Lyons; Xin Zhou; Krishna Sinha; Pierre D McCrea; Benoit de Crombrugghe
Journal:  Proc Natl Acad Sci U S A       Date:  2008-05-05       Impact factor: 11.205

5.  Osteo-chondroprogenitor cells are derived from Sox9 expressing precursors.

Authors:  Haruhiko Akiyama; Jung-Eun Kim; Kazuhisa Nakashima; Gener Balmes; Naomi Iwai; Jian Min Deng; Zhaoping Zhang; James F Martin; Richard R Behringer; Takashi Nakamura; Benoit de Crombrugghe
Journal:  Proc Natl Acad Sci U S A       Date:  2005-10-03       Impact factor: 11.205

Review 6.  Heritable diseases of the skeleton. Part I: Molecular insights into skeletal development-transcription factors and signaling pathways.

Authors:  S Mundlos; B R Olsen
Journal:  FASEB J       Date:  1997-02       Impact factor: 5.191

7.  Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts.

Authors:  T Komori; H Yagi; S Nomura; A Yamaguchi; K Sasaki; K Deguchi; Y Shimizu; R T Bronson; Y H Gao; M Inada; M Sato; R Okamoto; Y Kitamura; S Yoshiki; T Kishimoto
Journal:  Cell       Date:  1997-05-30       Impact factor: 41.582

8.  Cbfa1, a candidate gene for cleidocranial dysplasia syndrome, is essential for osteoblast differentiation and bone development.

Authors:  F Otto; A P Thornell; T Crompton; A Denzel; K C Gilmour; I R Rosewell; G W Stamp; R S Beddington; S Mundlos; B R Olsen; P B Selby; M J Owen
Journal:  Cell       Date:  1997-05-30       Impact factor: 41.582

9.  Osteoprotegerin: a novel secreted protein involved in the regulation of bone density.

Authors:  W S Simonet; D L Lacey; C R Dunstan; M Kelley; M S Chang; R Lüthy; H Q Nguyen; S Wooden; L Bennett; T Boone; G Shimamoto; M DeRose; R Elliott; A Colombero; H L Tan; G Trail; J Sullivan; E Davy; N Bucay; L Renshaw-Gegg; T M Hughes; D Hill; W Pattison; P Campbell; S Sander; G Van; J Tarpley; P Derby; R Lee; W J Boyle
Journal:  Cell       Date:  1997-04-18       Impact factor: 41.582

10.  TIEG1 null mouse-derived osteoblasts are defective in mineralization and in support of osteoclast differentiation in vitro.

Authors:  Malayannan Subramaniam; Genevieve Gorny; Steven A Johnsen; David G Monroe; Glenda L Evans; Daniel G Fraser; David J Rickard; Kay Rasmussen; Jan M A van Deursen; Russell T Turner; Merry Jo Oursler; Thomas C Spelsberg
Journal:  Mol Cell Biol       Date:  2005-02       Impact factor: 4.272

View more
  77 in total

1.  Expression of master regulatory genes controlling skeletal development in benign cartilage and bone forming tumors.

Authors:  Jane Y Dancer; Stephen P Henry; Jolanta Bondaruk; Sangkyou Lee; Alberto G Ayala; Benoit de Crombrugghe; Bogdan Czerniak
Journal:  Hum Pathol       Date:  2010-12       Impact factor: 3.466

2.  Maturation of cortical bone suppresses periosteal osteoprogenitor proliferation in a paracrine manner.

Authors:  Young Jae Moon; Chi-Young Yun; Jeong-Chae Lee; Jung Ryul Kim; Byung-Hyun Park; Eui-Sic Cho
Journal:  J Mol Histol       Date:  2016-07-09       Impact factor: 2.611

3.  Synthesis and characterization of biomimetic citrate-based biodegradable composites.

Authors:  Richard T Tran; Liang Wang; Chang Zhang; Minjun Huang; Wanjin Tang; Chi Zhang; Zhongmin Zhang; Dadi Jin; Brittany Banik; Justin L Brown; Zhiwei Xie; Xiaochun Bai; Jian Yang
Journal:  J Biomed Mater Res A       Date:  2013-08-30       Impact factor: 4.396

4.  Cyclic tensile stress during physiological occlusal force enhances osteogenic differentiation of human periodontal ligament cells via ERK1/2-Elk1 MAPK pathway.

Authors:  Lu Li; Minxuan Han; Sheng Li; Lin Wang; Yan Xu
Journal:  DNA Cell Biol       Date:  2013-06-19       Impact factor: 3.311

5.  KDM1A regulated the osteo/dentinogenic differentiation process of the stem cells of the apical papilla via binding with PLOD2.

Authors:  Lijun Wang; Haoqing Yang; Xiao Lin; Yangyang Cao; Peipei Gao; Ying Zheng; Zhipeng Fan
Journal:  Cell Prolif       Date:  2018-04-15       Impact factor: 6.831

6.  The transcriptional activity of osterix requires the recruitment of Sp1 to the osteocalcin proximal promoter.

Authors:  Corinne Niger; Florence Lima; David J Yoo; Rishi R Gupta; Atum M Buo; Carla Hebert; Joseph P Stains
Journal:  Bone       Date:  2011-07-28       Impact factor: 4.398

7.  Epiphyseal chondrocyte secondary ossification centers require thyroid hormone activation of Indian hedgehog and osterix signaling.

Authors:  Weirong Xing; Shaohong Cheng; Jon Wergedal; Subburaman Mohan
Journal:  J Bone Miner Res       Date:  2014-10       Impact factor: 6.741

8.  Axin2+-Mesenchymal PDL Cells, Instead of K14+ Epithelial Cells, Play a Key Role in Rapid Cementum Growth.

Authors:  X Xie; J Wang; K Wang; C Li; S Zhang; D Jing; C Xu; X Wang; H Zhao; J Q Feng
Journal:  J Dent Res       Date:  2019-08-27       Impact factor: 6.116

9.  Neuropeptide Y regulates the hematopoietic stem cell microenvironment and prevents nerve injury in the bone marrow.

Authors:  Min Hee Park; Hee Kyung Jin; Woo-Kie Min; Won Woo Lee; Jeong Eun Lee; Haruhiko Akiyama; Herbert Herzog; Grigori N Enikolopov; Edward H Schuchman; Jae-sung Bae
Journal:  EMBO J       Date:  2015-04-27       Impact factor: 11.598

Review 10.  Genetic and molecular control of osterix in skeletal formation.

Authors:  Krishna M Sinha; Xin Zhou
Journal:  J Cell Biochem       Date:  2013-05       Impact factor: 4.429

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.